"Translating Regeneration into Life"
The Journal of Translational Regenerative Medicine (JTRM) is an international, peer-reviewed, open-access journal dedicated to advancing the science and clinical practice of regenerative and translational biomedicine. The journal provides a global platform for disseminating high-quality research that bridges laboratory discovery and clinical application, fostering innovation across the entire translational continuum — from fundamental biology to patient care.
Our mission is to connect fundamental biological insights with real-world therapeutic outcomes by promoting multidisciplinary collaboration among experts in Stem cell biology, Biomaterials science, Molecular medicine, Nanotechnology, Biomedical engineering, and Clinical translation. JTRM aims to accelerate the safe and effective transformation of laboratory innovations into clinical therapies that improve health and quality of life worldwide.
The journal welcomes submissions covering, but not limited to, the following domains:
Stem Cell Biology: Isolation, expansion, and lineage-specific differentiation of pluripotent, multipotent, and adult stem cells.
Tissue Engineering and Regenerative Biomaterials: Design and evaluation of smart scaffolds, bioactive polymers, hydrogels, and advanced biofabrication methods.
Gene and Epigenetic Therapies: Application of CRISPR/Cas systems, gene modulation, and epigenome editing for regenerative and reparative purposes.
3D Bioprinting and Organoid Models: Development, fabrication, and functional assessment of patient-specific or disease-model tissue constructs.
Drug Delivery and Nanomedicine: Design of nano- and micro-carrier systems, targeted delivery strategies, and stimuli-responsive therapeutic platforms.
Immunoengineering and Immunomodulation: Modulation of the immune microenvironment to enhance tissue repair and regeneration.
Translational and Clinical Research: Preclinical models, early-phase clinical trials, safety and regulatory frameworks, and real-world translational studies.
Systems Biology and Omics Approaches: Genomics, proteomics, metabolomics, and single-cell profiling to uncover regenerative mechanisms.
Ethics, Policy, and Commercialization: Bioethics, intellectual property, manufacturing and quality standards, and the societal dimensions of regenerative medicine.
JTRM publishes a wide range of article types, including original research articles, systematic and narrative reviews, short communications, technical notes, and clinical case studies. The journal also welcomes editorials, perspectives, and policy discussions that stimulate debate and shape the future of translational regenerative medicine.
We prioritize methodological rigor, reproducibility, and translational impact. Submissions that demonstrate a clear “bench-to-bedside” pathway—linking discovery to clinical benefit—are given special consideration. Through this commitment, JTRM seeks to serve as a trusted forum for advancing evidence-based innovation in regenerative healthcare.